Lu AA24530 shows positive results in major depressive disorder phase II study
03-Jul-2009 -
H. Lundbeck A/S announced positive headline results from a dose finding clinical trial with the compound Lu AA24530 for the treatment of major depressive disorder (MDD). The primary objective of the study was to compare the efficacy of three doses of Lu AA24530, 5, 10 and 20 mg, to that of ...
clinical trials
depressions
drug development
+4